CYP3A5 expression was correlated positively with HNF1A+ and negatively with KRT81–, and also contributed to acquired resistance in the QM-PDA and Classical subtypes (Noll et al., 2016). This evidence concerns the gene HNF1A and Patent ductus arteriosus.